Lubka T. Roumenina mainly focuses on Atypical hemolytic uremic syndrome, Immunology, Complement system, Alternative complement pathway and Factor H. In his study, Molecular biology, Endocrinology and C5-convertase is inextricably linked to Internal medicine, which falls within the broad field of Atypical hemolytic uremic syndrome. Lubka T. Roumenina specializes in Immunology, namely C3-convertase.
He works in the field of Complement system, namely CD46. His biological study spans a wide range of topics, including Classical complement pathway, Pathogenesis and Complement receptor. While the research belongs to areas of Factor H, Lubka T. Roumenina spends his time largely on the problem of Cell biology, intersecting his research to questions surrounding Neutrophil extracellular traps and Granulocyte.
Lubka T. Roumenina focuses on Immunology, Complement system, Atypical hemolytic uremic syndrome, Alternative complement pathway and Complement factor B. Lubka T. Roumenina focuses mostly in the field of Immunology, narrowing it down to matters related to Glomerulopathy and, in some cases, Polyclonal antibodies. His Complement system research is multidisciplinary, incorporating elements of Hemolysis, Molecular biology and Complement.
The Atypical hemolytic uremic syndrome study combines topics in areas such as Endothelial stem cell, Glomerulonephritis, Internal medicine, Pathogenesis and Eculizumab. Lubka T. Roumenina usually deals with Alternative complement pathway and limits it to topics linked to Cell biology and Endothelium. His study focuses on the intersection of Complement factor B and fields such as Complement factor I with connections in the field of Pathology.
The scientist’s investigation covers issues in Complement system, Immunology, Hemolysis, Alternative complement pathway and Cell biology. His Complement system study focuses mostly on C3-convertase and Atypical hemolytic uremic syndrome. His study looks at the intersection of C3-convertase and topics like Autoantibody with Complement factor B and Lupus nephritis.
His work deals with themes such as Diagnostic marker and Glomerulopathy, which intersect with Immunology. The Alternative complement pathway study which covers Classical complement pathway that intersects with Cancer. His Cell biology research incorporates themes from RAGE and Glycation.
Lubka T. Roumenina focuses on Complement system, Hemolysis, Endothelium, Inflammation and Hemopexin. A significant part of his Complement system research incorporates Immunology and Antibody studies. He studies C3-convertase which is a part of Immunology.
His Hemolysis study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Complement System Part I - Molecular Mechanisms of Activation and Regulation.
Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Sarah Elizabeth Church;Sarah Elizabeth Church;Sarah Elizabeth Church;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina.
Frontiers in Immunology (2015)
Complement System Part II: Role in Immunity.
Nicolas S. Merle;Remi Noe;Lise Halbwachs-Mecarelli;Veronique Fremeaux-Bacchi.
Frontiers in Immunology (2015)
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée.
Journal of The American Society of Nephrology (2010)
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec.
Kidney International (2012)
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Julien Zuber;Fadi Fakhouri;Lubka T. Roumenina;Chantal Loirat.
Nature Reviews Nephrology (2012)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza.
Kidney International (2017)
Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort
Jane E. Salmon;Cara Heuser;Michael Triebwasser;M. Kathryn Liszewski.
PLOS Medicine (2011)
Complement factor H related proteins (CFHRs)
Christine Skerka;Qian Chen;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina.
Molecular Immunology (2013)
C1q and its growing family
Rohit Ghai;Patrick Waters;Lubka T. Roumenina;Mihaela Gadjeva.
Immunobiology (2007)
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation.
Laurent Camous;Lubka Roumenina;Sylvain Bigot;Soumeya Brachemi.
Blood (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Inserm : Institut national de la santé et de la recherche médicale
Université Paris Cité
Université Paris Cité
Université Paris Cité
Brunel University London
Washington University in St. Louis
Inserm : Institut national de la santé et de la recherche médicale
Mario Negri Institute for Pharmacological Research
Inserm : Institut national de la santé et de la recherche médicale
University of Iowa
Inserm : Institut national de la santé et de la recherche médicale
Publications: 83
Carnegie Mellon University
Yangzhou University
Friedrich Schiller University Jena
Clemson University
Spanish National Research Council
Centre national de la recherche scientifique, CNRS
Boston University
Japan Agency for Marine-Earth Science and Technology
Kyushu University
Max Planck Society
University of Leeds
University of Waikato
University of Pennsylvania
Florida State University
King's College London
University of Pittsburgh